引用本文: | 胡晓云, 陈锦章, 王森锐. 阿替利珠单抗联合贝伐珠单抗与索拉非尼应用于不可切除肝细胞癌的疗效对比[J]. 循证医学, 2021, 21(6): 325-328. DOI: 10.12019/j.issn.1671-5144.2021.06.002 |
Citation: | HU Xiao-yun, CHEN Jin-zhang, WANG Sen-rui. Efficacy Comparison Between Atezolizumab Plus Bevacizumab and Sorafenib in Unresectable Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 325-328. DOI: 10.12019/j.issn.1671-5144.2021.06.002 |